The purpose of the American Cancer Society/American Society of Clinical Oncology Breast
Cancer Survivorship Care Guideline is to provide recommendations to assist primary care …

Background Several guidelines have been reported for bone-directed treatment in women
with early breast cancer (EBC) for averting fractures, particularly during aromatase inhibitor …

There are three distinct areas of cancer management that make bone health in cancer
patients of increasing clinical importance. First, bone metastases are common in many solid …

PURPOSE The aim of this work is to provide evidence-based guidance on the management
of osteoporosis in survivors of adult cancer. METHODS ASCO convened a multidisciplinary …

Purpose To make recommendations regarding the use of bisphosphonates and other bone-
modifying agents as adjuvant therapy for patients with breast cancer. Methods Cancer Care …

Bone metastasis is a major cause of morbidity in persons with cancer. Complications include
pain, impaired mobility, pathological fracture, spinal cord compression, cranial nerve …

Background Bone is the most common site of metastatic disease associated with breast
cancer (BC). Bisphosphonates inhibit osteoclast‐mediated bone resorption, and novel …

The number of patients surviving≥ 5 years after initial cancer diagnosis has significantly
increased during the last decades due to considerable improvements in the treatment of …

Bisphosphonates have been studied in randomised trials in early breast cancer to
investigate their ability to prevent cancer treatment-induced bone loss (CTIBL) and reduce …

Preservation of bone health remains a long-term clinical challenge in patients with breast
and prostate cancer. Osteoporosis, defined by a loss of bone mass and microarchitecture …